Transcriptional repression of RORα Activity in human breast cancer cells by melatonin

Molecular and Cellular Endocrinology

Volumn 176, Issue 1-2, 2001, Pages 111-120

  Dai, Jun ^a   Ram, Prahiad T ^a   Yuan, Lin ^a   Spriggs, Louaine L ^a   Hill, Steven M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer cells; Melatonin; ROR receptors

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; MELATONIN; RETINOIC ACID RECEPTOR; ANTIOXIDANT; CALMODULIN; CELL RECEPTOR; DNA; DNA BINDING PROTEIN; ISOPROTEIN; MESSENGER RNA; PROTEIN KINASE (CALCIUM,CALMODULIN); RAR RELATED ORPHAN RECEPTOR A; RAR-RELATED ORPHAN RECEPTOR A; TRANSACTIVATOR PROTEIN;

ARTICLE; BREAST CANCER; CALCIUM SIGNALING; CELL STRAIN MCF 7; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SERUM; TRANSACTIVATION; WESTERN BLOTTING; BREAST TUMOR; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIOXIDANTS; BLOTTING, WESTERN; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM SIGNALING; CALMODULIN; DNA; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELATONIN; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035946833     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00449-X     Document Type: Article

References (45)

1. Acuna-Castroviejo D., Reiter R.J., Menendez-Palaez A., Pablos M.I., Burgos A. Characterization of high affinity melatonin binding sites in purified cell nuclei of rat liver. J. Pineal Res. 16:1994;100-112.
2. Becker-André M., Wiesenberg I., Schaeren-Wiemers N., André E., Missbash M., Saurat J.-H., Carlberg C. Pineal gland hormone melatonin binds and activates an orphan receptor of the nuclear receptor superfamily. J. Biol. Chem. 269:1994;28531-28534.
3. 3H-melatonin to calmodulin. Life Sci. 53:1993a;201-207.
4. Benítez-King G., Antón-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia. 49:1993b;635-641.
5. Benítez-King G., Rios A., Martínez A., Antón-Tay F. In vitro inhibition of Ca/calmodulin dependent protein kinase II activity by melatonin. Biochem. Biophys. Acta. 1290:1996;191-196.
6. Blask D.E., Hill S.M. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J. Neural Transm. Suppl. 21:1986;433-449.
7. q/11 proteins. Mol. Endocrinol. 13:1999;2025-2038.
8. Cohen M., Lippman M., Chabner B. Role of pineal gland in etiology and treatment of breast cancer. Lancet. 2:1978;814-816.
9. Dai, J., Hill, S.M., 1999. Pineal gland hormone melatonin regulates transcriptional activity of RORα in MCF-7 breast cancer cells. Exp. Biol. 2000, Abstract 187.6, San Diego, CA, p. 268.
10. Dixon C.J., Bowler W.B., Fleetwood P., Ginty A.F., Gallagher J.A., Carron J.A. Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors. Br. J. Cancer. 75:1997;34-39.
11. 125I]Iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution. Endocrinology. 122:1988;1825-1833.
12. Dussault I., Giguère V. Differential regulation of the N-myc proto-oncogene by RORα and RVR, two orphan members of the superfamily of nuclear hormone receptors. Mol. Cell. Biol. 17:1997;1860-1867.
13. Ebisawa T., Karne S., Lerner M.R., Reppert S.M. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc. Natl. Acad. Sci. USA. 91:1994;6133-6137.
14. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
15. 2-purinergic receptors in human breast tumor cells: coupling of intracellular calcium signaling to anion secretion. J. Pharmacol. Exp. Ther. 265:1993;1499-1510.
16. Giguère V., Tini M., Flock G., Ong E.S., Evans R.M., Otulakowski G. Isoform specific amino-terminal domains dictate DNA-binding properties of RORα, a novel family of orphan hormone nuclear receptors. Genes Dev. 8:1994;538-553.
17. Gudas L.J. Retinoids, retinoid-response genes, cell differentiation and cancer. Cell Growth Diff. 3:1992;655-662.
18. Hazelrigg D.G., Thompson M., Hastings M.H., Morgan P.J. Regulation of mitogen-activated protein kinase in the pars tuberalis of ovine pituitary, interaction between melatonin, insulin-like growth factor- 1, and forskolin. Endocrinology. 137:1996;210-218.
19. Hill S.M., Blask D.E. Effects of the pineal hormone on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:1988;6121-6126.
20. Hill S.M., Spriggs L.L., Simon M.A., Muraoka H., Blask D.E. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett. 64:1992;249-256.
21. Horwitz K.B., Jackson T.A., Bain D.L., Richer J.K., Takimoto G.S., Tung L. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1996;1167-1177.
22. 2+/calmodulin-dependent protein kinase IV. EMBO J. 19:2000;691-701.
23. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotch Y., Nishide E., Chambon P. Activation of the estrogen receptor through phosphorylation by the mitogen activated protein kinase. Science. 270:1995;1491-1494.
24. Kleinman H.K., Benjamin S.W., Schnaper H.W., Kibbey M.C., Yamamura K., Grant D.S. The laminins: a family of basement membrane glycoproteins important in cell differentiation and tumor metastases. Vitam. Horm. 47:1993;161-186.
25. Matsui T. Differential activation of the murine laminin B1 gene promoter by RARα, RORα, and AP-1. Biochem. Biophys. Res. Commun. 220:1996;405-410.
26. McBroom L.D.B., Flock G., Giguère V. The non-conserved hinge region and distinct amino-terminal domains of the RORα orphan nuclear receptor isoforms are required for proper DNA bending and RORα-DNA interactions. Mol. Cell. Biol. 15:1995;796-808.
27. McNulty S., Ross A.W., Barrett P., Hastings M.H., Morgan P.J. Melatonin regulates the phosphorylation of CREB in ovine pars tuberalis. J. Neuroendocrinol. 6:1994;523-532.
28. Molis T.M., Walters M.R., Hill S.M. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. Int. J. Oncol. 3:1993;687-694.
29. Molis T.M., Spriggs L.L., Hill S.M. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol. 8:1994;1681-1690.
30. Molis T.M., Spriggs L.L., Jupiter Y., Hill S.M. Melatonin modulation of estrogen-regulated proteins, growth factors, and protooncogenes in human breast cancer. J. Pineal Res. 18:1995;93-103.
31. Ram P.T., Kiefer T., Silverman M., Song Y., Brown G.M., Hill S.M. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol. Cell. Endocrinol. 141:1998;53-64.
32. Rato A.G., Pedrero J.G., Martinez M.A., Rio B.D., Lazo P.S., Ramos S. Melatonin blocks the activation of estrogen receptor for DNA binding. FASEB J. 13:1999;857-868.
33. Reppert S.M., Weaver D.R., Godson C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol. Sci. 17:1996;100-102.
34. Schräder M., Danielsson C., Wiesenberg I., Carlberg C. Identification of natural monomeric response elements of the nuclear receptor RZR/ROR. J. Biol. Chem. 271:1996;19732-19736.
35. Steinhilber D., Brungs M., Werz O., Wiesenberg I., Danielsson C., Kahlen J.-P., Nayeri S., Schräder M., Carlberg C. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J. Biol. Chem. 270:1995;7037-7040.
36. Strobl J.S., Peterson V.A., Woodfork K.A. A survey of human breast cancer sensitivity to growth inhibition by calmodulin antagonists in tissue culture. Biochem. Pharmacol. 47:1994;2157-2161.
37. Takimoto G.S., Hovland A.R., Tasset D.M., Melville M.Y., Tung L., Horwitz K.B. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J. Biol. Chem. 271:1996;13308-13316.
38. Tapp E. The pineal gland in malignancy. Reiter R.J. The Pineal Gland. 3:1982;171-188 CRC Press, Boca Raton.
39. Tini M., Fraser R.A., Giguère V. Functional interactions between retinoic acid-related orphan nuclear receptor (RORα) and the retinoic acid receptors in the regulation of the rF-crystallin promoter. J. Biol. Chem. 270:1995;20156-20161.
40. Vanecek J. Cellular mechanisms of melatonin action. Physiol. Rev. 78:1998;687-721.
41. 2+ in neonatal rat pituitary cells. Endocrinology. 130:1992;701-707.
42. Weigel N.L., Zhang Y. Ligand-independent activation of steroid hormone receptors. J. Mol. Med. 76:1998;469-479.
43. Wiesenberg I., Missbach M., Kahlen J.-P., Schräder M., Carlberg C. Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23:1995;327-333.
44. 2/calmodulin-dependent protein kinase inhibitor KN-62 (1 [N,O-bis (5-isoquinolinesulfonyl)-N-methyl-tyrosyl]4-phenylpiperazine) in small cell lung carcinoma. Biochem. Pharmacol. 51:1996;707-715.
45. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is A universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.